Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0000950170-25-050924
Filing Date
2025-04-04
Accepted
2025-04-04 10:10:13
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B4 apvo-2025-pro-sup_-_shel.htm 424B4 774102
2 GRAPHIC img139778278_0.jpg GRAPHIC 6172
3 GRAPHIC img139778278_1.jpg GRAPHIC 199177
4 GRAPHIC img139778278_2.jpg GRAPHIC 225492
5 GRAPHIC img139778278_3.jpg GRAPHIC 4507
6 GRAPHIC img139778278_4.jpg GRAPHIC 199177
7 GRAPHIC img139778278_5.jpg GRAPHIC 250435
8 GRAPHIC img139778278_6.jpg GRAPHIC 4056
  Complete submission text file 0000950170-25-050924.txt   2000025
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-284969 | Film No.: 25812329
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)